Neutral
[8-K] Vistagen Therapeutics, Inc. Reports Material Event
Vistagen Therapeutics, Inc. reported a material event in an 8-K filing, detailing the approval of retention awards in the form of stock option grants ...
Vistagen Therapeutics, Inc. reported a material event in an 8-K filing, detailing the approval of retention awards in the form of stock option grants ...